• Home

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Metachromatic leukodystrophy

• Overview
• Symptoms
• Treatment
• Prevention

Definition:

Metachromatic leukodystrophy (MLD) is a genetic disorder that affects nerves, muscles, and other organs. It slowly gets worse over time.

Alternative Names:

MLD; Arylsulfatase A deficiency; Leukodystrophy - metachromatic

Causes, incidence, and risk factors:

MLD is usually caused by the lack of an important enzyme called arylsulfatase A. Because this enzyme is missing, chemicals called sulfatides accumulate in the nervous system, kidneys, gallbladder, and other organs. The sulfatides damage the nerves and organs where buildup occurs. In particular, it damages the myelin sheaths that surround nerve cells.

The disease is inherited as an autosomal recessive genetic disorder. This means you must get a copy of the defective gene from both your parents. Those who only get a defective gene from only one parent, the child usually does not develop MLD.

Parents can each have the defective gene, but not have MLD. A person with one defective gene is called a "carrier." When two carriers have a child, there is a 25% chance that the child will get both genes and have MLD.

MLD occurs in about 1 per 40,000 people. There are three forms of the disease. They are based on when the symptoms begin.

• Late infantile MLD symptoms usually begin by age 4 and include walking problems and loss of muscle control and mental functions.
• Juvenile MLD symptoms usually between age 4 and 6. The child has trouble walking and loses developmental milestones. The first sign may be problems with school performance.
• Adult and late-stage juvenile MLD symptoms usually occur slowly. They may occur between age 6-16 and adult (over age 16). Early symptoms include behavior problems, loss of mental functions and muscle control, poor school or work performance, and seizures.

• Review Date: 12/11/2006
• Reviewed By: Brian Kirmse, MD, Mount Sinai School of Medicine, Department of Human Genetics, New York, NY. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.